Acorda Therapeutics President and CEO Ron Cohen Receives New York Biotechnology Association Business Leader of the Year Award

HAWTHORNE, N.Y.--(BUSINESS WIRE)--Acorda Therapeutics, Inc. (Nasdaq: ACOR) today announced that Ron Cohen, M.D., President and Chief Executive Officer, is the recipient of the New York Biotechnology Association (NYBA) “The Cures Start Here” Business Leader of the Year Award. The award is presented for outstanding service to the patient community and to NYBA.
MORE ON THIS TOPIC